Guidelines, Education Permit Safe Outpatient Use of RIT Radioimmunotherapy

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 11 No 7
Volume 11
Issue 7

WASHINGTON-In 1997, the Nuclear Regulatory Commission issued new guidelines for radiation therapy that, for the first time, permitted outpatient use of radioactive iodine therapy in selected patients (ie, highly compliant patients discharged to low-occupancy settings). Previously, this therapy had required inpatient treatment and 3 days of isolation.

WASHINGTON—In 1997, the Nuclear Regulatory Commission issued new guidelines for radiation therapy that, for the first time, permitted outpatient use of radioactive iodine therapy in selected patients (ie, highly compliant patients discharged to low-occupancy settings). Previously, this therapy had required inpatient treatment and 3 days of isolation.

High Level of Staff Education

Outpatient care involving radioimmunotherapy (RIT) is "more convenient" and "less expensive," but requires a high level of staff education to be done safely, said Carolyn Hendrix, RN, OCN, manager of the Cancer Outpatient Treatment Clinic of the Hoag Cancer Center, Hoag Hospital, Newport Beach, California.

At a poster session of the 27th Annual Congress of the Oncology Nursing Society (abstract 71), she described a model developed at Hoag for treating non-Hodgkin’s lymphoma patients with the investigational RIT iodine-131 tositumomab (Bexxar). The successful use of the treatment program, she said, demonstrates the feasibility of the outpatient approach.

‘Distance, Time, and Shielding’

"Distance, time, and shielding" are the keys to safe RIT treatment, Ms. Hendrix said. Nurses must be trained to work efficiently so that contact with patients getting radioactive antibodies is minimized. The treatment must take place away from highly traveled areas of the hospital (in a lead-shielded isolation room), and all staff involved with these patients must wear badges to monitor radiation.

Patients and staff must be educated about the dangers of radiation and the steps that can lessen them, Ms. Hendrix said.

On discharge, she said, patients must receive explicit and detailed instructions on the restrictions that must be observed after radioimmunotherapy (see Table). These instructions include sleeping in a separate bed, staying 6 feet or more away from children and pregnant women, avoiding long trips, limiting time in public places, and generally assuring that other people do not come into direct contact with either patients or their bodily fluids.

Related Videos
Investigators must continue to explore the space for lisocabtagene maraleucel in mantle cell lymphoma, according to Manali Kamdar, MD.
Those with CML should discuss adverse effects such as nausea or fatigue with their providers to help optimize their quality of life during treatment.
A panel of 4 experts on multiple myeloma
A panel of 4 experts on multiple myeloma
Patients with CML can become an active part of their treatment plan by discussing any questions that come to mind with their providers.
A panel of 4 experts on multiple myeloma
Video 1 - 4 KOLs are featured in "Treating Patients Referred to Academic Centers for CAR T"
Video 1 - 4 KOLs are featured in "Identifying Potential Candidates for CAR T-Cell Therapy"
Beth Faiman, CNP, PhD, an expert on multiple myeloma